Bainbridge Jacquelyn, Barnhart Rebecca, Fuller Ryan, Hellerslia Van T, Kidd Julie, Merrill Steven, Volger Emily, Montgomery Jenelle H
From the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA (JB).
University of Colorado Health, Ambulatory Care Pharmacy Services, Aurora, CO, USA (RB).
Int J MS Care. 2024 Jan-Feb;26(1):1-7. doi: 10.7224/1537-2073.2022-051. Epub 2024 Jan 5.
Individuals with multiple sclerosis (MS) may experience a variety of visible and invisible symptoms and, as they age, comorbidities related and unrelated to their MS. This can result in a complex medication regimen that includes disease-modifying therapies, symptom management drugs, and prescriptions for other comorbid disorders.
We reviewed the existing literature to discover how to optimally integrate neurology clinical pharmacists into the MS care team and how clinical pharmacists can directly support both providers and patients through their expertise in pharmacology and medication management.
With approaches founded on a shared decision-making process alongside neurology providers, patients, and care partners, clinical pharmacists can help meet the complex challenges of MS care in a variety of ways. Especially within MS clinics, they are well positioned to enhance current neurology practices given their extensive training in comprehensive medication management and their ability to identify nuances in medication management to promote pharmacovigilance and patient-centered care.
Neurology clinical pharmacists bring multifaceted medication management and patient counseling and education skills to the MS care team and can support the shared decision-making process by serving as an accessible resource for patients and clinicians. By building trusted partnerships between neurology providers and clinical pharmacists, MS care teams can achieve effective and efficient patient care. Future research should compare clinical and patient-reported outcomes between patients receiving standard care and those receiving multidisciplinary, pharmacist-integrated care.
多发性硬化症(MS)患者可能会出现各种可见和不可见的症状,并且随着年龄增长,还会出现与MS相关和不相关的合并症。这可能导致复杂的药物治疗方案,包括疾病修正疗法、症状管理药物以及针对其他合并症的处方。
我们回顾了现有文献,以了解如何将神经科临床药师最佳地融入MS护理团队,以及临床药师如何通过其药理学和药物管理专业知识直接支持医疗服务提供者和患者。
通过基于与神经科医疗服务提供者、患者和护理伙伴共同决策过程的方法,临床药师可以通过多种方式帮助应对MS护理的复杂挑战。特别是在MS诊所内,鉴于他们在全面药物管理方面的广泛培训以及识别药物管理细微差别以促进药物警戒和以患者为中心的护理的能力,他们非常适合加强当前的神经科医疗实践。
神经科临床药师为MS护理团队带来多方面的药物管理以及患者咨询和教育技能,并可以通过作为患者和临床医生可获取的资源来支持共同决策过程。通过在神经科医疗服务提供者和临床药师之间建立可信赖的伙伴关系,MS护理团队可以实现高效的患者护理。未来的研究应比较接受标准护理的患者与接受多学科、药师整合护理的患者之间的临床和患者报告结局。